m. VANCOUVER, April 11 - Placer Dome Inc.placerdome.com

held meeting

V.
Interested parties should consult the DOV Web site for such details as the
Company may announce its participation in such events and conferences via the
Web site , and not press releases, in the future.

held meeting

com, for 90 days following the
conferences.

paris economics

Countries where SBS currently
has broadcasting assets include: Belgium (Flanders), Denmark, Finland, Greece,
Hungary , The Netherlands, Norway, Romania and Sweden.

Placer Dome announces first quarter conference call and Annual Meeting webcast

paris sciences

SBS is a European commercial television and radio broadcasting company
with operations in Western and Central Europe.J., DOV Pharmaceutical,
Inc. (Nasdaq: DOVP ) announced today that the Company will host a corporate
booth and present five posters at the American Pain Society's 25th Annual
Scientific Meeting in San Antonio, Texas to be held May 3-6, 2006.

An audio webcast and accompanying slide
presentation will be accessible at http://www.

abstracts denmark

About DOV
DOV is a biopharmaceutical company focused on the discovery, acquisition,
development and commercialization of novel drug candidates for central nervous
system disorders.

2003 paris

Placer Dome's first quarter conference call will be held at 10:00am
Eastern time/7:00am Pacific time.
The webcasts of the presentations may, but not necessarily will, include
forward-looking statements concerning Placer Dome's current outlook for 2005
and other areas relating to Placer Dome's business .

presented 2003

- 9:45 a.com/investors/webcasts.html.com/investors/webcasts.
Archived versions of both webcasts will be available for replay shortly
following the live events. The
Vancouver-based company's shares trade on the Toronto, New York, Swiss and
Australian stock exchanges and Euronext-Paris under the symbol PDG.

lago european

: SBS) announced today its participation
at the Bear Stearns 14th Annual Global Credit Conference being held on
Tuesday, May 17, 2005 and Wednesday, May 18, 2005 at the Waldorf-Astoria Hotel
in New York, New York.

italy conferences

Company Also Announces it Will Present at Upcoming Conferences in March and
April 2006

HACKENSACK, N.

italy annual

Our partner Neurocrine has filed two NDAs for the use of DOV's compound
indiplon for the treatment of insomnia.

epcs paris

aarhus held

DOV also announced today that Dr.

belgirate held

A webcast of
the presentation will not be provided for this conference .

DOV Pharmaceutical Inc. to Present Bicifadine Posters at American Pain Society Scientific Meeting

dovpharm.html.

papers lago

The DOV
posters and published abstracts will focus on bicifadine, the Company's novel
analgesic, and provide additional information and scientific data, including:

* Bicifadine as an efficacious analgesic in animal models of neuropathic
pain

* Characterization of bicifadine's molecular pharmacology and efficacy in
animal models of acute pain

* An overview of data from the completed Phase III trial of bicifadine and
tramadol versus placebo in the treatment of postoperative bunionectomy
pain

* An overview of data from the ongoing Phase III open label safety and
efficacy trial of bicifadine for the treatment of chronic low back pain

* Data regarding single-dose and repeat-dose bicifadine pharmacokinetics
in healthy adult male human subjects

Members of the DOV preclinical research, clinical development and senior
management teams will be attending the conference and will be available to
discuss the posters with meeting attendees. Additionally, the Company will make presentations at the CIBC World
Markets Annual Biotechnology + Specialty Pharmaceuticals Conference to be held
in New York City on April 4-5, 2006 and at the UBS Global Pharmaceuticals
Conference to be held in New York City on April 24-25, 2006.

lago sciences

For further information visit: http://www. Canada V7X 1P1
Tel: (604) 682-7082
On the internet: http://www.

presented denmark

placerdome.C.

presented italy

DOV
presentations will be archived and available on the Investor Relations section
of the Company's Web site, http://www . (NYSE, TSX,
ASX: PDG) will hold its first quarter conference call and Annual Meeting of
Shareholders on Wednesday, April 27, 2005.

Conferences sponsored by the European Public Choice Society

abstracts held

com.placerdome . A video webcast of the
meeting will also be accessible at http://www.
Placer Dome employs 13,000 people at 17 mines in seven countries.

maggiore choice

sbsbroadcasting.C.

For further information please contact:
Investor Relations: Greg Martin (604) 661-3795
Meghan Brown (604) 661-1577
Media Relations: Gayle Stewart (604) 661-1911
Toll-free within North America 1-800-565-5815

Head office
Suite 1600, Bentall IV
1055 Dunsmuir Street
(PO Box 49330,
Bentall Postal Station )
Vancouver, B.

papers 2001

Eastern Time. Phil Skolnick, CSO and Senior Vice
President of Research, will present at the 4th Annual Psychiatric Disorders in
Drug Discovery + Development Conference to be held in Boston on March 27-28,
2006.
More details about these events and upcoming conferences at which DOV will
present can be found on the Calendar section of the Company's Web site.

annual lago

LUXEMBOURG , SBS Broadcasting SA
(Nasdaq: SBTV; Euronext Amsterdam N.m.

presented meeting

SBS Broadcasting to Present at the Bear Stearns 14th Annual Global Credit Conference

Harry Evans Sloan, Executive Chairman is scheduled to present on
Wednesday, May 18, 2005 from 9:00 a.

epcs annual

Our product candidates address some of the largest
pharmaceutical markets in the world including insomnia, pain and depression.

belgirate social

Placer Dome's Annual Meeting of Shareholders will be held at 10:00am
Pacific time/1:00pm Eastern time in rooms 1-3 of the Vancouver Convention and
Exhibition Centre, 999 Canada Place, Vancouver , B.

sciences maggiore

---

- - kjjkjk

Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)